Xiaodan Liu

943 total citations
47 papers, 723 citations indexed

About

Xiaodan Liu is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Cancer Research. According to data from OpenAlex, Xiaodan Liu has authored 47 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 8 papers in Public Health, Environmental and Occupational Health and 7 papers in Cancer Research. Recurrent topics in Xiaodan Liu's work include Acute Lymphoblastic Leukemia research (8 papers), RNA modifications and cancer (7 papers) and Cancer-related molecular mechanisms research (5 papers). Xiaodan Liu is often cited by papers focused on Acute Lymphoblastic Leukemia research (8 papers), RNA modifications and cancer (7 papers) and Cancer-related molecular mechanisms research (5 papers). Xiaodan Liu collaborates with scholars based in China, Austria and United States. Xiaodan Liu's co-authors include Lina Wang, Chunbo Yan, Sylvain Richoz, Yanlong Chen, Xulong Lai, Jing He, Huimin Xia, Ruizhong Zhang, Tianyou Yang and Jinhong Zhu and has published in prestigious journals such as Cancer, Chemical Communications and International Journal of Molecular Sciences.

In The Last Decade

Xiaodan Liu

44 papers receiving 711 citations

Peers

Countries citing papers authored by Xiaodan Liu

Since Specialization

Citations

This map shows the geographic impact of Xiaodan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaodan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaodan Liu more than expected).

Fields of papers citing papers by Xiaodan Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaodan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaodan Liu. The network helps show where Xiaodan Liu may publish in the future.

Co-authorship network of co-authors of Xiaodan Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaodan Liu. A scholar is included among the top collaborators of Xiaodan Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaodan Liu. Xiaodan Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Potential therapeutic targets for ischemic stroke in pre-clinical studies: Epigenetic-modifying enzymes DNMT/TET and HAT/HDAC 2025 ·Frontiers in Pharmacology ·(unknown), (unknown), Xiaodan Liu, Huang Ding, Wei Zhang	1
2	PIWIL1 gene polymorphism and pediatric acute lymphoblastic leukemia relapse susceptibility among Chinese children: a five-center case–control study 2023 ·Frontiers in Oncology ·(unknown), Daowen Wang, (unknown), Yaping Yan, Shanshan Liu, Xiaodan Liu, Ailing Luo, (unknown), Xiaoping Liu, Hua Jiang	2
3	New association between splicing factor‐coding gene polymorphisms and the risk of acute lymphoblastic leukemia in southern Chinese children: A five‐center case–control study 2023 ·The Journal of Gene Medicine ·(unknown), Ailing Luo, Ming Li, Yaping Yan, (unknown), Shanshan Liu, Xiaodan Liu, Xueliang Wang, (unknown), Hua Jiang, (unknown), (unknown)	3
4	ADAR1 polymorphisms contribute to increased susceptibility in pediatric acute lymphoblastic leukemia 2023 ·Annals of Hematology ·(unknown), Xiaoping Liu, Ailing Luo, Xu Yang, Yaping Yan, Shanshan Liu, Xueliang Wang, (unknown), Xuedong Wu, Ke Huang, Lihua Yang, Hua Jiang, (unknown), Xiaodan Liu	2
5	Genetic variants in m5C modification core genes are associated with the risk of Chinese pediatric acute lymphoblastic leukemia: A five-center case–control study 2023 ·Frontiers in Oncology ·Xueliang Wang, (unknown), Yaping Yan, (unknown), Xiaodan Liu, (unknown), Ailing Luo, Shanshan Liu, (unknown), Hua Jiang, Xiaoping Liu	4
6	Enhanced Taq Variant Enables Efficient Genome Editing Testing and Mutation Detection 2022 ·The CRISPR Journal ·(unknown), Bo Li, Xiaodan Liu, Lele Yang, (unknown), Yingying Li, Qilai Huang	4
7	Exosomal microRNAs induce tumor-associated macrophages via PPARγ during tumor progression in SHH medulloblastoma 2022 ·Cancer Letters ·(unknown), Ying Yang, (unknown), Luzheng Xu, (unknown), Yantao Liu, Zongran Liu, Xiaodan Liu, Danfeng Zheng, (unknown), Jiaqi Li, Chao Song, Bao Yang, Jianyuan Luo, Qing Chang	26
8	Colorimetric ELISA based on urease catalysis curcumin as a ratiometric indicator for the sensitive determination of aflatoxin B1 in grain products 2022 ·Talanta ·Huang Dai, (unknown), Xiaodan Liu, Jie Bi, Zaixi Shu, (unknown), Jiahua Wang	40
9	Differential lipidomics of HK-2 cells and exosomes under high glucose stimulation 2022 ·International Journal of Medical Sciences ·Weidong Wang, Tingting Li, Zhijie Li, Hongmiao Wang, Xiaodan Liu	8
10	Bufalin Induces Programmed Necroptosis in Triple-Negative Breast Cancer Drug-Resistant Cell Lines through RIP1/ROS-Mediated Pathway 2021 ·Chinese Journal of Integrative Medicine ·Xiaodan Liu, (unknown), Cuicui Kong, Xin Tian	18
11	CircRNF220, not its linear cognate gene RNF220, regulates cell growth and is associated with relapse in pediatric acute myeloid leukemia 2021 ·Molecular Cancer ·Xiaodan Liu, Xiaoping Liu, (unknown), Ailing Luo, Yingyi He, Sha Liu, Xiaohong Zhang, Xu Yang, (unknown), Hua Jiang	38
12	LINCS gene expression signature analysis revealed bosutinib as a radiosensitizer of breast cancer cells by targeting eIF4G1 2021 ·International Journal of Molecular Medicine ·Sai Hu, Dafei Xie, Ping‐Kun Zhou, Xiaodan Liu, Xiaoyao Yin, Bo Huang, Hua Guan	5
13	Novel Associations Between METTL3 Gene Polymorphisms and Pediatric Acute Lymphoblastic Leukemia: A Five-Center Case-Control Study 2021 ·Frontiers in Oncology ·Xiaoping Liu, Libin Huang, Ke Huang, Lihua Yang, Xu Yang, Ailing Luo, (unknown), Xuedong Wu, Xiaodan Liu, Yaping Yan, (unknown), Yun Cai, (unknown), Hua Jiang	11
14	Genome-wide identification of DNA-PKcs-associated RNAs by RIP-Seq 2019 ·Signal Transduction and Targeted Therapy ·Zhiquan Song, (unknown), (unknown), Han Yang, Hua Guan, Xiaodan Liu, Teng Ma, Ping‐Kun Zhou	16
15	Association of Common Genetic Variants in Pre-microRNAs and Neuroblastoma Susceptibility: A Two-Center Study in Chinese Children 2018 ·Molecular Therapy — Nucleic Acids ·Jing He, Yan Zou, Xiaodan Liu, Jinhong Zhu, Jiao Zhang, Ruizhong Zhang, Tianyou Yang, Huimin Xia	91
16	Associations of maternal PLA2G4C and PLA2G4D polymorphisms with the risk of spontaneous preterm birth in a Chinese population 2017 ·Molecular Medicine Reports ·Guangjian Liu, Jianrong He, Yashu Kuang, Xuejiao Fan, Weidong Li, Jinhua Lu, Xiaoyan Xia, Xiaodan Liu, Niannian Chen, (unknown), Huimin Xia, Xiu Qiu	6
17	Upregulation of the proto-oncogene Bmi-1 predicts a poor prognosis in pediatric acute lymphoblastic leukemia 2017 ·BMC Cancer ·Hongxia Peng, Xiaodan Liu, (unknown), (unknown), Xue‐Qun Luo, Xiaohong Chen, Hua Jiang, (unknown)	19
18	Influence of Xuefuzhuyu decoction on EPC repairing injured vascular endothelium 2016 ·Zhongguo yaolixue tongbao ·Wei Zhang, Xiaodan Liu, Fei Li, (unknown), Chang-Qing Deng	0
19	C1q and tumor necrosis factor-related protein 3 is present in human cord blood and is associated with fetal growth 2015 ·Clinica Chimica Acta ·Niannian Chen, Jianrong He, Weidong Li, Yashu Kuang, Mingyang Yuan, Xiaodan Liu, Huizhu Zhang, (unknown), Huimin Xia, Xiu Qiu	2
20	Clinical observation of the combination of all-trans retinoic acid with arsenic trioxide on newly-diagnosed patients of acute promyelocytic leukemia 2008 ·Xiaodan Liu	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact